Results 251 to 260 of about 124,738 (260)

Nucleoside reverse transcriptase inhibitors

Reactions Weekly, 2003
openaire   +1 more source

Non-nucleoside reverse transcriptase inhibitors—an overview

International Journal of STD & AIDS, 2003
C, Bell, G V, Matthews, M R, Nelson
openaire   +2 more sources

Virtual screening studies on HIV-1 reverse transcriptase inhibitors to design potent leads

European Journal of Medicinal Chemistry, 2011
S Vadivelan, Rambabu Gundla, Barij Nayan Sinha   +2 more
exaly  

Non‐nucleoside reverse transcriptase inhibitors: a review on pharmacokinetics, pharmacodynamics, safety and tolerability

Journal of the International AIDS Society, 2013
Iris usach, José Esteban Peris
exaly  

Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy

Lancet, The, 1999
Kees Brinkman, Johannes A Romijn, J A Romijn   +2 more
exaly  

Protease inhibitors/nucleoside reverse transcriptase inhibitors

Reactions Weekly, 2020
openaire   +1 more source

Comparative study of non nucleoside inhibitors with HIV-1 reverse transcriptase based on 3D-QSAR and docking

SAR and QSAR in Environmental Research, 2003
H F Chen, A Panaye, J P Doucet
exaly  

Nucleoside reverse transcriptase inhibitors

Reactions Weekly, 1998
openaire   +1 more source

Nonnucleoside reverse transcriptase inhibitors.

AIDS clinical care, 1997
openaire   +1 more source

Definition of pharmacophore for nonnucleoside reverse transcriptase inhibitors.

2002
A. RAO, J. BALZARINI, M. L. BARRECA, A. CHIMIRRI, E. DE CLERCQ, DE LUCA, Laura, MONFORTE, Anna Maria, P. MONFORTE, C. PANNECOUQUE, ZAPPALA', Maria   +9 more
openaire   +2 more sources